Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes results from the acute catheterization and urgent intervention triage strategy (ACUITY) trial

Circulation: Cardiovascular Interventions

Volumn 3, Issue 4, 2010, Pages 308-316

  Lansky, Alexandra J ^a   Goto, Kenji ^a   Cristea, Ecaterina ^a   Fahy, Martin ^a   Parise, Helen ^a   Feit, Frederick ^b,d   Ohman, E Magnus ^c   White, Harvey D ^e   Alexander, Karen P ^c   Bertrand, Michel E ^f   Desmet, Walter ^g   Hamon, Martial ^h   Mehran, Roxana ^a   Moses, Jeffrey ^a   Leon, Martin ^a   Stone, Gregg W ^a  

^a NewYork Presbyterian Hospital   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Medicine ^*  (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e AUCKLAND CITY HOSPITAL   (New Zealand)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h University Hospital   (France)

Author keywords

Acute coronary syndromes; Angiography; Early invasive strategy; Predictor; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; CREATINE KINASE MB; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN; HEPARIN; HIRULOG; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; THIENOPYRIDINE DERIVATIVE; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY CALCIFICATION; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART CATHETERIZATION; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRACARDIAC THROMBOSIS; INVASIVE PROCEDURE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SMOKING; ST SEGMENT ELEVATION;

EID: 78650159622     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.109.887604     Document Type: Article

References (29)

1. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE III, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC Jr. American College of Cardiology; American Heart Association. Committee on the Management of Patients With Unstable Angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: A report of the American College of Cardiology/ American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40:1366-1374.
2. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadDen E, De Feyter PJ, Specchia G, Ruzyllo W. Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002;23: 1809-1840. (Pubitemid 35398051)
3. Pieper KS, Tsiatis AA, Davidian M, Hasselblad V, Kleiman NS, Boersma E, Chang WC, Griffin J, Armstrong PW, Califf RM, Harrington RA. Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: Exploration of methods. Circulation. 2004;109: 641-646. (Pubitemid 38198872)
4. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. J Am Med Assoc. 2000;284:835-842. (Pubitemid 30643610)
5. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA; GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: Estimating the risk of 6-month postdischarge death in an international registry. J Am Med Assoc. 2004;291:2727-2733. (Pubitemid 38725422)
6. Westerhout CM, Fu Y, Lauer MS, James S, Armstrong PW, Al-Hattab E, Califf RM, Simoons ML, Wallentin L, Boersma E; GUSTO-IV ACS Trial Investigators. Short- and long-term risk stratification in acute coronary syndromes: The added value of quantitative ST-segment depression and multiple biomarkers. J Am Coll Cardiol. 2006;48:939-947. (Pubitemid 44292443)
7. Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, Colombo A, Aylward PE, Cequier AR, Darius H, Desmet W, Ebrahimi R, Hamon M, Rasmussen LH, Rupprecht HJ, Hoekstra J, Mehran R, Ohman EM. ACUITY Investigators. Bivalirudin for patients with acute coronary syndromes. N Eng J Med. 2006;355:2203-2216. (Pubitemid 44791162)
8. Stone GW, Ware JH, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Manoukian SV, Fahy M, Clayton TC, Mehran R, Pocock SJ. ACUITY Investigators. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: One-year results from the ACUITY trial. J Am Med Assoc. 2007;298:2497-2506. (Pubitemid 350223536)
9. Stone GW, Bertrand M, Colombo A, Dangas G, Farkouh ME, Feit F, Lansky AJ, Lincoff AM, Mehran R, Moses JW, Ohman M, White HD. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale. Am Heart J. 2004;148: 764-775.
10. Lansky A, Popma J. Qualitative and quantitative angiography. In: Topol EJ, ed. Textbook of Interventional Cardiology, ed III. Philadelphia: WB Saunders; 1999:725-747.
11. Costantini CO, Stone GW, Mehran R, Aymong E, Grines CL, Cox DA, Stuckey T, Turco M, Gersh BJ, Tcheng JE, Garcia E, Griffin JJ, Guagliumi G, Leon MB, Lansky AJ. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol. 2004;44:305-312. (Pubitemid 38950587)
12. Califf RM, Phillips HR III, Hindman MC, Mark DB, Lee KL, Behar VS, Johnson RA, Pryor DB, Rosati RA, Wagner GS. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5:1055-1063. (Pubitemid 15050990)
13. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101:570-580. (Pubitemid 30080873)
14. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: Implications for Patient Selection Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82:1193-1202.
15. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, Van Den Brand M, Van Dyck N, Russell ME, Serruys PW. The SYNTAX score: An angiographic tool grading the complexity of coronary artery disease. Eurointervention. 2005;1:219-227.
16. Fragmin and Fast Revascularization During Instability in Coronary Artery Disease (FRISC II) Investigators. Long-term low-molecular-mass heparin in unstable coronary artery disease: FRISC II prospective randomized multicentre study. Lancet. 1999;354:701-707.
17. Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, Guneri S, Gurfinkel E, Harrington R, Hochman JS, Kleiman NS, Leon MB, Lopez-Sendon JL, Pepine CJ, Ruzyllo W, Steinhubl SR, Teirstein PS, Toro-Figueroa L, White H; SYNERGY Trial Investigators. Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. J Am Med Assoc. 2004;292:45-54. (Pubitemid 38923793)
18. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E; TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)- Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-1887.
19. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ. Randomized Intervention Trial of Unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: The British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of Unstable Angina. Lancet. 2002;360: 743-751. (Pubitemid 35247703)
20. Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA, Schwartz RS. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burDen in humans: A histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol. 1998;31:126-133. (Pubitemid 28064732)
21. Raggi P, Callister TQ, Cooil B, He ZX, Lippolis NJ, Russo DJ, Zelinger A, Mahmarian JJ. IDentification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 2000;101:850-855. (Pubitemid 30117879)
22. Mollet NR, Cademartiri F, Nieman K, Saia F, Lemos PA, McFadDen EP, Serruys PW, Krestin GP, de Feyter PJ. Noninvasive assessment of coronary plaque burDen using multislice computed tomography. Am J Cardiol. 2005;95:1165-1169. (Pubitemid 40616417)
23. Tuzcu EM, Berkalp B, De Franco AC, Ellis SG, Goormastic M, Whitlow PL, Franco I, Raymond RE, Nissen SE. The dilemma of diagnosing coronary calcification: Angiography versus intravascular ultrasound. J Am Coll Cardiol. 1996;27:832-838. (Pubitemid 26104864)
24. Kirtane AJ, Kosmidou I, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM; TIMI Study Group. Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy. Am J Cardiol. 2005;95:337-342. (Pubitemid 40164536)
25. Moussa I, Ellis SG, Jones M, Kereiakes DJ, McMartin D, Rutherford B, Mehran R, Collins M, Leon MB, Popma JJ, Russell ME, Stone GW. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). Am J Cardiol. 2005;96:1242-1247. (Pubitemid 41505401)
26. de Ribamar Costa J Jr, Mintz GS, Carlier SG, Fujii K, Sano K, Kimura M, Tanaka K, Costa RA, Lui J, Na Y, Castellanos C, Biro S, Moussa I, Stone GW, Moses JW, Leon MB. Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J. 2007;153:297-303. (Pubitemid 46096874)
27. Takebayashi H, Kobayashi Y, Mintz GS, Carlier SG, Fujii K, Yasuda T, Moussa I, Mehran R, Dangas GD, Collins MB, Kreps E, Lansky AJ, Stone GW, Leon MB, Moses JW. Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. Am J Cardiol. 2005;95:498-502. (Pubitemid 40247548)
28. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, Leon MB, Moses JW, Yock PG, Honda Y, Kuntz RE, Fitzgerald PJ; SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: Serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol. 2004;43: 1959-1963. (Pubitemid 38686788)
29. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study. J Am Coll Cardiol. 2005;45:995-998. (Pubitemid 40432428)